Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $825.40 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $221.74 | 15 | $0 (2024) |
| GENZYME CORPORATION | $127.48 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $118.72 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $67.39 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $50.25 | 3 | $0 (2024) |
| Amgen Inc. | $48.35 | 3 | $0 (2024) |
| Genentech USA, Inc. | $46.88 | 3 | $0 (2024) |
| CSL Behring | $45.30 | 2 | $0 (2024) |
| Phadia US Inc. | $20.07 | 1 | $0 (2024) |
| Lilly USA, LLC | $18.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $754.43 | 44 | AstraZeneca Pharmaceuticals LP ($206.17) |
| 2023 | $70.97 | 4 | GENZYME CORPORATION ($21.73) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Immunology | ||||||
| 11/11/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Immunology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Immunology | ||||||
| 07/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Immunology | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 67 | 72 | $9,704 | $3,968 |
| 2022 | 6 | 163 | 165 | $17,172 | $8,210 |
| 2021 | 8 | 245 | 250 | $24,490 | $12,998 |
| 2020 | 5 | 271 | 276 | $13,022 | $7,150 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 39 | $5,421 | $2,143 | 39.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $2,363 | $1,306 | 55.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 15 | 16 | $1,920 | $519.30 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 44 | $6,116 | $3,170 | 51.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 58 | 59 | $7,080 | $2,345 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $1,068 | $1,051 | 98.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $1,946 | $913.17 | 46.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $494.00 | $486.72 | 98.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 12 | $468.00 | $243.76 | 52.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 91 | 94 | $11,280 | $4,252 | 37.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $4,031 | $2,845 | 70.6% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 29 | 29 | $2,871 | $1,970 | 68.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 27 | $3,033 | $1,626 | 53.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $816.00 | $816.00 | 100.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,068 | $632.76 | 59.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 23 | 23 | $897.00 | $499.79 | 55.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 19 | 19 | $494.00 | $357.29 | 72.3% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 211 | 214 | $8,346 | $4,695 | 56.3% |
| 87426 | Coronavirus ag ia | Office | 2020 | 23 | 24 | $1,890 | $1,086 | 57.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 14 | $1,946 | $622.93 | 32.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $528.00 | $527.12 | 99.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $312.00 | $219.83 | 70.5% |
About Lisa Wydra
Lisa Wydra is a Family healthcare provider based in Hazlet, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1780916916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Wydra has received a total of $825.40 in payments from pharmaceutical and medical device companies, with $754.43 received in 2024. These payments were reported across 48 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($825.40).
As a Medicare-enrolled provider, Wydra has provided services to 746 Medicare beneficiaries, totaling 763 services with total Medicare billing of $32,327. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Hazlet, NJ
- Active Since 02/15/2010
- Last Updated 01/24/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1780916916
Products in Payments
- FASENRA (Biological) $221.74
- DUPIXENT (Biological) $177.73
- HYQVIA (Biological) $57.21
- TEZSPIRE (Biological) $48.35
- Xolair (Biological) $46.88
- Haegarda (Biological) $45.30
- NUCALA (Biological) $34.68
- TRELEGY ELLIPTA (Drug) $32.71
- CUVITRU (Biological) $26.64
- ImmunoCAP (Device) $20.07
- EOHILIA (Drug) $18.16
- TALTZ (Drug) $18.13
- AUVI-Q (Drug) $16.96
- TAKHZYRO (Biological) $16.71
- LAGEVRIO (Drug) $16.04
- Xembify (Biological) $14.29
- XOLAIR (Drug) $13.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hazlet
Ms. Deatte Gettinger
Family — Payments: $1,780
Shannon Dorgan
Family — Payments: $1,394
Joseph Napoli, Fnp, FNP
Family — Payments: $228.26
Mr. Misael Dimatulac, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $127.05
Jessica Turro, Fnp-C, FNP-C
Family — Payments: $86.08
Devan D'aloia, Fnp-Bc, FNP-BC
Family — Payments: $18.79